Puma Biotechnology (PBYI) Payables (2017 - 2025)
Historic Payables for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $6.4 million.
- Puma Biotechnology's Payables fell 1495.54% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 1495.54%. This contributed to the annual value of $5.5 million for FY2024, which is 2003.19% down from last year.
- Per Puma Biotechnology's latest filing, its Payables stood at $6.4 million for Q3 2025, which was down 1495.54% from $5.4 million recorded in Q2 2025.
- Puma Biotechnology's 5-year Payables high stood at $20.0 million for Q3 2021, and its period low was $5.1 million during Q3 2023.
- Moreover, its 5-year median value for Payables was $7.8 million (2023), whereas its average is $9.1 million.
- Per our database at Business Quant, Puma Biotechnology's Payables tumbled by 6609.5% in 2023 and then surged by 7318.79% in 2024.
- Puma Biotechnology's Payables (Quarter) stood at $11.2 million in 2021, then crashed by 42.37% to $6.4 million in 2022, then rose by 6.97% to $6.9 million in 2023, then fell by 20.03% to $5.5 million in 2024, then grew by 15.92% to $6.4 million in 2025.
- Its Payables was $6.4 million in Q3 2025, compared to $5.4 million in Q2 2025 and $6.0 million in Q1 2025.